Surveillance for Nonmuscle Invasive Bladder Cancer: Identifying the Point of Diminishing Returns

Daniel Ranti1, Linda Dey2, Christine Bieber1

  • 1Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY.

Urology
|August 21, 2023
PubMed
Summary

This study analyzed bladder cancer recurrence patterns over 26 years. Patients without recurrence at 5 years may benefit from less intensive monitoring, regardless of initial risk category.